SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,390,000 | -7.5% | 405,000 | 0.0% | 0.13% | -10.9% |
| Q3 2019 | $3,665,000 | -16.0% | 405,000 | 0.0% | 0.15% | -16.5% |
| Q2 2019 | $4,362,000 | +14.3% | 405,000 | +1.2% | 0.18% | +12.8% |
| Q1 2019 | $3,816,000 | -16.9% | 400,000 | 0.0% | 0.16% | -8.2% |
| Q4 2018 | $4,592,000 | -9.7% | 400,000 | +33.3% | 0.17% | +28.8% |
| Q3 2018 | $5,085,000 | +79.0% | 300,000 | +50.0% | 0.13% | +120.0% |
| Q2 2018 | $2,840,000 | -0.4% | 200,000 | +33.3% | 0.06% | +66.7% |
| Q1 2018 | $2,850,000 | – | 150,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |